Federation Des Caisses Desjardins Du Quebec Anixa Biosciences Inc Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 600 shares of ANIX stock, worth $1,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600Holding current value
$1,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
63Shares Held
5.48MCall Options Held
24.5KPut Options Held
23.4K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.48 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.56 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.54 Million0.01% of portfolio
-
Ubs Group Ag524KShares$1.31 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.17 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $76.7M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...